Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Mitchell

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
JAMA Oncology|August 4, 2017
Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance ImagingMandy L Ballinger, Nicholas J Ferris, Kate Moodie, et al.
BMC Cancer|June 28, 2011
A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genesHeather L Hondow, Stephen B Fox, Gillian Mitchell, et al.
Parasites & Vectors|November 14, 2019
Habitat and host factors associated with liver fluke (Fasciola hepatica) diagnoses in wild red deer (Cervus elaphus) in the Scottish HighlandsAndrew S French, Ruth N Zadoks, Philip J Skuce, et al.
Advanced Genetics (Hoboken, N.J.)|January 9, 2023
The Risk-Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational LeafletRajneesh Kaur, Cassandra McDonald, Bettina Meiser, et al.
BMC Cancer|March 7, 2018
A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer preventionGillian E Hanley, Jessica N McAlpine, Dianne Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2006
Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary taleYoland C Antill, Gillian Mitchell, Sandra A Johnson, et al.
Breast Cancer Research and Treatment|May 15, 2012
Analysis of KLLN as a high-penetrance breast cancer predisposition geneElla R Thompson, Kylie L Gorringe, David Y H Choong, et al.
The Breast Journal|December 8, 2018
Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancerSarah Sutherland, Bettina Meiser, Rajneesh Kaur, et al.
ANZ Journal of Surgery|February 3, 2012
Practicalities of developing a breast magnetic resonance imaging screening service for women at high risk for breast cancerBelinda E Kiely, Lucinda K Hossack, Clair L Shadbolt, et al.
Oncology Nursing Forum|March 1, 2012
Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testingBettina Meiser, Margaret Gleeson, Kaaren Watts, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
JAMA Oncology|August 4, 2017
Surveillance in Germline TP53 Mutation Carriers Utilizing Whole-Body Magnetic Resonance ImagingMandy L Ballinger, Nicholas J Ferris, Kate Moodie, et al.
BMC Cancer|June 28, 2011
A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genesHeather L Hondow, Stephen B Fox, Gillian Mitchell, et al.
Parasites & Vectors|November 14, 2019
Habitat and host factors associated with liver fluke (Fasciola hepatica) diagnoses in wild red deer (Cervus elaphus) in the Scottish HighlandsAndrew S French, Ruth N Zadoks, Philip J Skuce, et al.
Advanced Genetics (Hoboken, N.J.)|January 9, 2023
The Risk-Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational LeafletRajneesh Kaur, Cassandra McDonald, Bettina Meiser, et al.
BMC Cancer|March 7, 2018
A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer preventionGillian E Hanley, Jessica N McAlpine, Dianne Miller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2006
Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary taleYoland C Antill, Gillian Mitchell, Sandra A Johnson, et al.
Breast Cancer Research and Treatment|May 15, 2012
Analysis of KLLN as a high-penetrance breast cancer predisposition geneElla R Thompson, Kylie L Gorringe, David Y H Choong, et al.
The Breast Journal|December 8, 2018
Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancerSarah Sutherland, Bettina Meiser, Rajneesh Kaur, et al.
ANZ Journal of Surgery|February 3, 2012
Practicalities of developing a breast magnetic resonance imaging screening service for women at high risk for breast cancerBelinda E Kiely, Lucinda K Hossack, Clair L Shadbolt, et al.
Oncology Nursing Forum|March 1, 2012
Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testingBettina Meiser, Margaret Gleeson, Kaaren Watts, et al.
Pageof 12